Chiron Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,200
| Closed | -$233K | – | 124 |
|
|
2021
Q4 | $233K | Sell |
10,200
-3,300
| -24% | -$75.4K | 0.17% | 97 |
|
|
2021
Q3 | $299K | Buy |
13,500
+1,700
| +14% | +$37.7K | 0.22% | 79 |
|
|
2021
Q2 | $153K | Buy |
11,800
+692
| +6% | +$8.97K | 0.13% | 76 |
|
|
2021
Q1 | $144K | Buy |
+11,108
| New | +$144K | 0.12% | 70 |
|
|
2020
Q4 | – | Sell |
-9,700
| Closed | -$143K | – | 108 |
|
|
2020
Q3 | $143K | Buy |
+9,700
| New | +$143K | 0.12% | 87 |
|